ArticleBreast cancer research and treatment2025
Collateral damage: rhabdomyolysis from concurrent abemaciclib and rosuvastatin use.
Tae Hoon Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it